Medicare Part B Drug Denied — How to Appeal Coverage Decisions

Most people know that Medicare Part D covers prescription drugs you pick up at a pharmacy. But there's a second category of drug coverage many seniors don't fully understand: Medicare Part B drug coverage, which applies to medications administered by a healthcare provider in a clinical setting.

If your Part B drug was denied — whether it's a chemotherapy infusion, a biologic injection, or a drug administered during a procedure — this guide explains what's covered, why denials happen, and how to fight back.

What Drugs Does Medicare Part B Cover?

Medicare Part B covers drugs that are:

• Administered by a healthcare provider — typically injected, infused, or implanted in a physician's office, clinic, or outpatient hospital setting
• Not generally self-administered — Part B historically covered drugs that patients typically don't administer themselves at home (though this distinction has been evolving with biologics and specialty drugs)

Common Part B drug categories include:

• Injectable cancer drugs (chemotherapy) administered in oncology offices
• Infused biologics for conditions like rheumatoid arthritis, Crohn's disease, multiple sclerosis (e.g., infliximab, rituximab, natalizumab)
• Injectable osteoporosis drugs (e.g., denosumab/Prolia, zoledronic acid/Reclast)
• Immunosuppressants after organ transplants
• Certain vaccines (like flu and pneumococcal shots — though these go through Part B, not Part D)
• Erythropoiesis-stimulating agents for dialysis patients or chemotherapy-related anemia
• Anti-nausea drugs given with chemotherapy
• Intravenous immune globulin (IVIG) for certain diagnosed conditions

Part B pays 80% of the Medicare-approved amount after the Part B deductible. You pay the remaining 20% (which a Medigap plan may cover).

Why Part B Drug Claims Get Denied

Medical necessity. The most common denial reason. The insurer or Medicare contractor concludes that the drug wasn't medically necessary for your diagnosis or clinical situation. Your physician's documentation needs to clearly connect your diagnosis to the specific drug and explain why it is the appropriate treatment.

Off-label use not supported by recognized compendia. Many Part B drugs are used for diagnoses not in their FDA approval label. Medicare Part B should cover off-label uses listed in accepted compendia — specifically NCCN Drug and Biologics Compendium, Drugdex (Micromedex), or Clinical Pharmacology. If the denial cites off-label use, your physician should provide the specific compendium citation supporting the use for your diagnosis.

Drug classification dispute. Medicare Advantage plans sometimes classify a drug as a Part D drug (pharmacy benefit) rather than a Part B drug (medical benefit), or vice versa. This classification affects how the claim is processed. If your plan is routing your claim through the wrong benefit, this is a correctable administrative error.

Step therapy or formulary restrictions (Medicare Advantage). Some Medicare Advantage plans require you to try one or more less expensive alternatives before approving a specific drug. For serious conditions, step therapy can be clinically inappropriate. Your physician can request a step therapy exception with documentation of why the alternatives are unsuitable.

Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization not obtained. Many Medicare Advantage plans require prior authorization for high-cost Part B drugs. If authorization was skipped, the claim may be denied. However, if the drug was clinically urgent and there was no time to obtain prior authorization, document this in your appeal.

Frequency limitations exceeded. Some drugs have Medicare coverage guidelines that specify how often they can be administered. If your treatment schedule doesn't align with standard guidelines, your physician should document the clinical rationale.

How to Appeal a Part B Drug Denial

Under Original Medicare:

File a Redetermination with the Medicare Administrative Contractor within 120 days of the denial. Include:

• Physician's Letter of Medical Necessity with your diagnosis, the drug prescribed, and clinical justification
• Relevant medical records supporting the diagnosis and treatment plan
• For off-label use: citations from NCCN, Drugdex, or Clinical Pharmacology supporting the use
• Any applicable clinical trial or FDA expanded access documentation if relevant

Under Medicare Advantage:

File a formal appeal with your plan within 60 days of the denial. Request expedited review (72-hour response) if your physician documents that standard timelines would harm your health.

Also consider asking your physician to request a peer-to-peer review with the plan's medical director — this step often produces faster results, especially for biologics and specialty drug appeals.

Part D vs. Part B: What If Your Plan Misclassified the Drug?

Some drugs can be administered in a clinical setting (Part B) or dispensed for home use (Part D) depending on the circumstances. If your plan is claiming the drug is a Part D benefit (requiring pharmacy processing and a Part D copay structure) rather than a Part B benefit (processed through your medical benefit), and this classification is incorrect, this is worth raising explicitly in your appeal.

Contact Medicare at 1-800-MEDICARE if you need help determining which benefit should cover a specific drug.

Fight Back With ClaimBack

Part B drug denials are complex, but they are winnable with the right documentation and argument. ClaimBack walks you through the appeal process, helps you identify the correct denial basis, and generates a professional appeal letter ready to submit to your insurer.

Start your appeal at ClaimBack

Related Reading

• What Is Medical Necessity?
• How to Write an Insurance Appeal Letter
• Common Reasons Insurance Claims Are Denied